Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
B 130.68 1.15% 1.48
CRSP closed up 1.15 percent on Wednesday, June 23, 2021, on 75 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CRSP trend table...

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Overbought Stochastic Strength 0.00%
Doji - Bearish? Reversal 1.15%
Multiple of Ten Bearish Other 1.15%
Overbought Stochastic Strength 1.15%
200 DMA Support Bullish 0.82%
Multiple of Ten Bearish Other 0.82%
BB Squeeze Ended Range Expansion 0.82%
Overbought Stochastic Strength 0.82%
Up 3 Days in a Row Strength 0.82%
Older End-of-Day Signals for CRSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 19 hours ago
Up 2% about 19 hours ago
Upper Bollinger Band Resistance about 19 hours ago
Rose Above Previous Day's High about 19 hours ago
Up 1% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9

Is CRSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 220.15
52 Week Low 68.85
Average Volume 1,286,463
200-Day Moving Average 125.64
50-Day Moving Average 119.29
20-Day Moving Average 121.92
10-Day Moving Average 127.16
Average True Range 5.49
ADX 15.4
+DI 27.47
-DI 16.63
Chandelier Exit (Long, 3 ATRs) 116.42
Chandelier Exit (Short, 3 ATRs) 126.16
Upper Bollinger Bands 133.78
Lower Bollinger Band 110.06
Percent B (%b) 0.87
BandWidth 19.45
MACD Line 3.57
MACD Signal Line 2.52
MACD Histogram 1.0448
Fundamentals Value
Market Cap 9.23 Billion
Num Shares 70.7 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 413.54
Price-to-Sales 92.44
Price-to-Book 5.79
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 137.09
Resistance 3 (R3) 137.11 135.01 136.02
Resistance 2 (R2) 135.01 133.38 134.99 135.66
Resistance 1 (R1) 132.84 132.37 133.93 132.82 135.31
Pivot Point 130.74 130.74 131.28 130.72 130.74
Support 1 (S1) 128.57 129.11 129.66 128.55 126.05
Support 2 (S2) 126.47 128.10 126.45 125.70
Support 3 (S3) 124.30 126.47 125.34
Support 4 (S4) 124.28